Should You Buy 180 Life Sciences Corp (ATNF) Stock on Tuesday?

The market has been down on 180 Life Sciences Corp (ATNF) stock recently. ATNF gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

180 Life Sciences Corp has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ATNF!

See Full ATNF Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With ATNF Stock Today?

180 Life Sciences Corp (ATNF) stock has fallen -5.77% while the S&P 500 has gained 0.35% as of 2:48 PM on Tuesday, Mar 19. ATNF has fallen -$0.20 from the previous closing price of $3.38 on volume of 38,016 shares. Over the past year the S&P 500 has risen 30.77% while ATNF has fallen -91.69%. ATNF lost -$247.21 per share in the over the last 12 months. To screen for more stocks like 180 Life Sciences Corp click here.

More About 180 Life Sciences Corp

180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics. Click Here to get the full Stock Report for 180 Life Sciences Corp stock.